Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Invitation - Orexo Capital Markets Day, Stockholm, Sweden, March 17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
By: PR Newswire Association LLC. - 19 Feb 2020 | Back to overview list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UPPSALA, Sweden, Feb. 19, 2020 /PRNewswire/ -- Orexo AB (publ.), today invites investors, analysts and media to attend the company's Capital Markets Day, taking place in Stockholm, Sweden, on Members of Orexo's management team, including recently appointed EVP Digital Therapeutics, Dennis Urbaniak, will provide an update on the company's strategy, R&D pipeline and business opportunities within digital health. Also speaking will be Dr. Mario Weiss, CEO and Founder of GAIA AG, a global leader in digital therapeutics. https://financialhearings.com/event/12588/register/live_event
Robert Rönn, VP and Head of R&D, and Mike Sumner, Chief Medical Officer, will attend the Minor changes can be done in the agenda ahead of the event. About Orexo Orexo develops and commercializes improved pharmaceuticals and digital therapeutics, addressing unmet medical needs mainly within the growing space of addiction. Approved products are commercialized by Orexo in the US or worldwide via partners. Orexo's main market is the US for buprenorphine/naloxone products, where Orexo commercializes its lead product Zubsolv®, for the treatment of opioid use disorder. Total net sales for 2019 amounted to SEK 844.8 million and the number of employees was 128. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. The company is headquartered in Uppsala, Sweden, where research and development activities are performed. For more information about Orexo please visit, www.orexo.com. You can also follow Orexo on Twitter, @orexoabpubl, LinkedIn and YouTube. The information was submitted for publication at 8:00 am CET, on February 19, 2020. For further information, please contact: Orexo AB (publ.) This information was brought to you by Cision http://news.cision.com The following files are available for download:
View original content:http://www.prnewswire.com/news-releases/invitation---orexo-capital-markets-day-stockholm-sweden-march-17-301007318.html SOURCE Orexo |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2020 PR Newswire Association LLC. | Back to overview list |